الانتقال إلى المحتوى الرئيسي
xMedica

NCT06956014ClinicalTrials.gov

Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy

Multicenter, Double-blind, Randomized, Placebo-controlled Phase III Trial to Evaluate the Efficacy and Safety of the Full-spectrum Cannabis Extract VER-01 in Participants With Chronic Painful Lumbosacral Radiculopathy

قيد التجنيديقبل مشاركين الآن، وفقاً لسجل السجل.
التواصل مع هذه الدراسة

باختصار

The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not…

المرحلة 3مطلوب 810 مشاركين43 موقعاًدولة واحدة

الفئات

مسجَّلة في سجل واحد

يمكن أن تُسجَّل دراسة واحدة في عدة سجلات. نعرضها مرة واحدة ونربط بكل سجل نحتفظ به.

تُعرض معلومات التجربة كما نشرها السجل، بلغتها الأصلية.

هل أنت مهتم بهذه الدراسة؟

تسجيل الدخول أو أنشئ حسابًا لتسجيل اهتمامك ومتابعة هذه الدراسة.

How this study is set up

The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.

  • Present: Registered before enrolment beganFirst posted 2025-05-02; recorded start 2026-09-22
  • Present: Has a defined primary outcomeA primary outcome measure is listed in the record
  • Present: The primary outcome states a time frameThe primary outcome measure records a time frame
  • Present: Participants are randomly assignedAllocation is recorded as randomised
  • Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
  • Present: Uses blinding (masking)A masking level is recorded in the record
  • Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
  • Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
  • Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
  • Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
  • Present: Sponsor has 2 other studies in this databaseCounted from the lead sponsor named in the record (Vertanical GmbH)
  • Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
  • The record lists 1 condition.
  • Lead sponsor type recorded as: industry.
  • Intervention regulatory context: investigational, within a phased regulatory pathway.

Trial stature

Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.

Methodological rigourSTRONG

A strong methodological design for a phase 3 study, judged from its ClinicalTrials.gov record.

How this score is built
  • Randomised allocation20/20

    Participants are randomly allocated between arms

  • Blinding20/20

    Quadruple-blind

  • Control arm13/15

    Placebo / sham control arm

  • Primary-outcome specificity10/10

    Named primary outcome with a defined time frame

  • Endpoint type3/10

    Surrogate or intermediate endpoint (conservative default)

  • Multi-centre0/8

    Single site, or site count not stated

  • Data monitoring committee0/7

    No data monitoring committee stated

  • Prospective registration5/5

    Registered before the study start date

  • Protocol / SAP posted0/5

    No protocol or SAP posted to the registry

ScaleMEDIUM

A medium-sized study: 810 participants (target), run at 43 sites.

How this score is built
  • Enrolment29/40

    810 participants (target)

  • Site count0/25

    Site count not stated in the record

  • Country count0/15

    Country count not stated in the record

  • Planned duration7/10

    Planned over about 24 months

  • Sponsor scale1/10

    Vertanical GmbH has led 3 trials in our corpus

Investigator standingUNKNOWN

We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.

How this score is built
  • Investigator standing0/100

    No investigator recorded in the registry for this trial

These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.

ملخص

The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.

الحالات

  • Lumbosacral Radiculopathy

الأهلية

الأهلية
الجنسالجميع
الأعمار18 Years – لا حد أقصى
المتطوعون الأصحّاءلا

الأهلية كما كُتبت في السجل

Inclusion Criteria: * Participants ≥ 18 years of age, all sexes * Participant voluntarily provided written informed consent * Participant is willing and able to comply with scheduled visits, treatment plan, eDiary, and other trial-related procedures throughout trial participation Exclusion Criteria: * Pregnant or breastfeeding female patients * Known history of previous or current severe psychiatric disorder as per DSM-5 (e.g., schizophrenia, bipolar disorder, severe anxiety disorder, psychotic disorder, post-traumatic stress disorder), or currently taking antipsychotic medication * Cardiovascular event or clinically significant cardiac dysfunction (e.g., congestive heart failure, myocardial ischemia, arrhythmias, poorly controlled high blood pressure, congenital long QT syndrome) within 12 months or a cardiac disorder that, in the opinion of the investigator, would put the patient at risk of a clinically significant arrhythmia or myocardial infarction

الأهلية في عبارات بسيطة

لم تُقسَّم معايير هذا السجل إلى عبارات منفصلة بعد. نص السجل أعلاه كامل وهو النسخة المُعتمَدة.

تصميم الدراسة

تصميم الدراسة
نوع الدراسةتدخّلية
المرحلةالمرحلة 3
التخصيصمعشّاة
نموذج التدخّلPARALLEL
الغرض الأساسيTREATMENT
التعميةQUADRUPLE (4)
التجنيدمطلوب 810 مشاركين

الجهة الراعية والمتعاونون

  • Vertanical GmbH الجهة الراعية

الأذرع والتدخلات

  • VER-01 Dose 1EXPERIMENTAL
  • VER-01 Dose 2EXPERIMENTAL
  • PlaceboPLACEBO_COMPARATOR

التدخلات

  • أخرى Placebo

    Comparator without active ingredient

  • دواء VER-01

    Standardized soft extract from Cannabis sativa DKJ127 L., cannabis flos (Cannabis flower), corresponding to 19 mg Δ9-Tetrahydrocannabinol (THC) per ml drug product

مقاييس النتائج

  1. مقياس النتيجة الأولي

    Efficacy based on pain reduction

    The primary endpoint is the absolute change in mean leg pain intensity in the index leg measured on an 11-point numerical rating scale (NRS) at Treatment Week 12 compared to Baseline.

    الإطار الزمني From Baseline to Treatment Week 12

التواريخ

التواريخ
تاريخ البدء22 سبتمبر 2026 (فعلي)
الإتمام الأولي1 سبتمبر 2028 (تقديري)
الإتمام1 سبتمبر 2028 (تقديري)
أول نشر2 مايو 2025 (فعلي)
آخر تحديث19 نوفمبر 2026
النتائج منشورةغير مذكور في سجل السجل
آخر تأكيد للحالةنوفمبر 2026

فعلي يعني أن الحدث وقع. تقديري يعني أن الجهة الراعية تتوقعه. للكلمتين معنيان مختلفان.

المواقع

43 موقعاً قيد التجنيد

United States

United States
المنشأةالمدينةالولاية أو المنطقةالحالة
Central Texas Clinical Research, LLCAustinTexasقيد التجنيد
Boston Clinical TrialsBostonMassachusettsقيد التجنيد
Bradenton Research CenterBradentonFloridaقيد التجنيد
DFW Clinical TrialsCarrolltonTexasقيد التجنيد
Epic Medical Research - CarroltonCarrolltonTexasقيد التجنيد
Clinitiative - Clinical Trials of South Carolina - CharlestonCharlestonSouth Carolinaقيد التجنيد
Epic Medical Research - ChickashaChickashaOklahomaقيد التجنيد
Velocity Clinical Research - ClevelandClevelandOhioقيد التجنيد
Epic Medical Research - DeSotoDeSotoTexasقيد التجنيد
Mountain View Clinical ResearchDenverColoradoقيد التجنيد
Innovare Research Group IFriendswoodTexasقيد التجنيد
AGA Clinical TrialsHialeahFloridaقيد التجنيد
HD Research - Memorial Hermann VillageHoustonTexasقيد التجنيد
Perfizien Clinical Research LLCHoustonTexasقيد التجنيد
Synergy Groups Medical - Southeast HoustonHoustonTexasقيد التجنيد
Green Leaf Clinical TrialsJacksonvilleFloridaقيد التجنيد
R & H Clinical ResearchKatyTexasقيد التجنيد
Alliance for Multispecialty Research - KnoxvilleKnoxvilleTennesseeقيد التجنيد
Epic Clinical Research - LewisvilleLewisvilleTexasقيد التجنيد
Central Medical Research InstituteLong BeachCaliforniaقيد التجنيد
Tekton Research - LongmontLongmontColoradoقيد التجنيد
K2 Medical Research - Maitland IIMaitlandFloridaقيد التجنيد
Velocity Clinical Research - MedfordMedfordOregonقيد التجنيد
Alma Clinical ResearchMiamiFloridaقيد التجنيد
Floridian Research Institute LLC IMiamiFloridaقيد التجنيد
AMR MobileMobileAlabamaقيد التجنيد
Monroe Biomedical Research - MonroeMonroeNorth Carolinaقيد التجنيد
Alliance for Multispecialty Research - NorfolkNorfolkVirginiaقيد التجنيد
Conquest Research - Lake NonaOrlandoFloridaقيد التجنيد
Alfa Medical Research - Pembroke PinesPembroke PinesFloridaقيد التجنيد
Flourish Research - PhiladelphiaPlymouth MeetingPennsylvaniaقيد التجنيد
United Medical ResearchPort OrangeFloridaقيد التجنيد
Boeson ResearchProvoUtahقيد التجنيد
CenExel JBR - Salt Lake CitySalt Lake CityUtahقيد التجنيد
Elixia Clinical Research CollaborativeSpringfieldMassachusettsقيد التجنيد
Professional Health Care of PinellasSt. PetersburgFloridaقيد التجنيد
Velocity Clinical Research - SuffolkSuffolkVirginiaقيد التجنيد
Alliance for Multispecialty Research - Tempe ITempeArizonaقيد التجنيد
Alliance for Multispecialty Research - Wichita EastWichitaKansasقيد التجنيد
Grayline Research CenterWichita FallsTexasقيد التجنيد
Progressive Medicine of the Triad, LLCWinston-SalemNorth Carolinaقيد التجنيد
Conquest Research - Winter ParkWinter ParkFloridaقيد التجنيد
Vitalix ClinicalWorcesterMassachusettsقيد التجنيد

مستندات الدراسة

لا تُرتبط أي مستندات في سجل السجل هذا.

التغيّرات عبر الزمن

  1. 19 نوفمبر 2026

    أُضيف موقع

    11 sites added (43 total)

    3243

  2. 2 نوفمبر 2026

    أُضيف موقع

    9 sites added (32 total)

    2332

  3. 21 أكتوبر 2026

    أُضيف موقع

    1 site added (23 total)

    2223

  4. 19 أكتوبر 2026

    أُضيف موقع

    21 sites added (22 total)

    122

  5. 28 سبتمبر 2026

    تغيّرت الحالة

    Status changed from Not yet recruiting to Recruiting

    NOT_YET_RECRUITINGRECRUITING

  6. 28 سبتمبر 2026

    أُضيف موقع

    1 site added (1 total)

    01

  7. 28 سبتمبر 2026

    فُتح التجنيد

    Recruitment opened

    NOT_YET_RECRUITINGRECRUITING